# Vlado Perkovic

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/vlado-perkovic/

## Facts

| Field | Value |
| --- | --- |
| Citations | 65,478 |
| Field | Diabetes Treatment and Management |
| h-index | 120 |
| i10-index | 363 |
| Last Known Institution | New South Wales Department of Health |
| OpenAlex ID | https://openalex.org/A5027520502 |
| ORCID iD | 0000-0002-4257-7620 |
| Works | 775 |

## Researcher papers

Showing 12 of 51.

- [Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes](https://scholariq.org/papers/canagliflozin-and-cardiovascular-and-renal-events-in-type-2-diabetes/)
- [Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy](https://scholariq.org/papers/canagliflozin-and-renal-outcomes-in-type-2-diabetes-and-nephropathy/)
- [Worldwide access to treatment for end-stage kidney disease: a systematic review](https://scholariq.org/papers/worldwide-access-to-treatment-for-end-stage-kidney-disease-a-systematic-review/)
- [Chronic kidney disease](https://scholariq.org/papers/chronic-kidney-disease-2/)
- [Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk](https://scholariq.org/papers/effect-of-linagliptin-vs-placebo-on-major-cardiovascular-events-in-adults-with/)
- [Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis](https://scholariq.org/papers/pharmacological-blood-pressure-lowering-for-primary-and-secondary-prevention-of/)
- [Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials](https://scholariq.org/papers/impact-of-diabetes-on-the-effects-of-sodium-glucose-co-transporter-2-inhibitors/)
- [Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis](https://scholariq.org/papers/effects-of-intensive-blood-pressure-lowering-on-cardiovascular-and-renal-2/)
- [Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes](https://scholariq.org/papers/albuminuria-and-kidney-function-independently-predict-cardiovascular-and-renal/)
- [A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension](https://scholariq.org/papers/a-call-to-action-and-a-lifecourse-strategy-to-address-the-global-burden-of/)
- [Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy](https://scholariq.org/papers/global-kidney-health-2017-and-beyond-a-roadmap-for-closing-gaps-in-care-research/)
- [Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis](https://scholariq.org/papers/effects-of-fibrates-on-cardiovascular-outcomes-a-systematic-review-and-meta/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)

## Researcher university

- [New South Wales Department of Health](https://scholariq.org/institutions/new-south-wales-department-of-health/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.